Assessing mRNA stability and integrity using mass photometry

Developing therapeutic applications for RNA-based products – such as mRNA vaccines – requires establishing analysis protocols for sample characterization. Mass photometry is a promising candidate since it provides fast, straightforward characterization of mRNA samples. Watch this webinar to learn:

• How cutting-edge, label-free technologies are reshaping RNA therapeutic development and quality control 
• How to overcome common RNA analysis bottlenecks with mass photometry
• How to apply mass photometry to evaluate small molecule interactions with RNA, supporting early-stage screening and drug development efforts with quantitative binding data